RC

Rakesh Chetani

Director Cfo DIN 06416725
DIN 06416725 First appointment Jun 2017 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Chetani

Data last updated:

Rakesh Chetani was a Cfo at Kimia Biosciences Limited (2023–2025) and Director at Zeus Buildcon Private Limited (from 2017). The companies operate in Pharma.

DIN 06416725
Primary Designation Cfo
Industry Pharma
First Appointment 15 Jun 2017
Oldest Company Age 16 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kimia Biosciences Limited L24239HR1993PLC032120
Cfo07 Sep 20231993₹120 Cr (FY 2025)Active
Zeus Buildcon Private Limited U70109DL2010PTC203093
Director15 Jun 20172010₹29.1 Lakh (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zeus Buildcon Private Limited
Kimia Biosciences Limited
Premium access

Shareholding and investment profile for Rakesh Chetani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Chetani

Rakesh Chetani was first appointed on 15 Jun 2017 as Director at Zeus Buildcon Private Limited. The most recent appointment on record is 07 Sep 2023 at Kimia Biosciences Limited.

Rakesh Chetani held 2 earlier board appointments: Kimia Biosciences Limited (Cfo, 07 Sep 2023 to 11 May 2025); Zeus Buildcon Private Limited (Director, from 15 Jun 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available